Table 3 Estimated mean percentages of new patients treated with defined anti-thrombotic therapies
| Â | When you see new patients with atrial fibrillation, for what percentage do you administer the following anti-thrombotic therapies? | ||||
|---|---|---|---|---|---|
|  | All (n = 331) | Geriatricians (n = 51) | Family doctors (n = 151) | Internal Medicine Specialists (n = 129) | P-value§ |
Warfarin | 72.6% | 76.4% | 71.9% | 71.9% | 0.28 |
no antithrombotic therapy | 5.4% | 4.9% | 5.3% | 5.8% | 0.21 |
Aspirin | 20.7% | 19.8% | 20.4% | 21.5% | 0.24 |
Plavix (Clopidogrel) | 4.2% | 3.8% | 5.2% | 3.2% | 0.11 |
Other | 2.9% | 1.6% | 2.7% | 3.6% | 0.46 |